BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37621322)

  • 1. KNTC1 knockdown inhibits proliferation and metastases of liver cancer.
    Yang F; Yuan C
    3 Biotech; 2023 Sep; 13(9):309. PubMed ID: 37621322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathway.
    Tong H; Liu X; Peng C; Shen B; Zhu Z
    Cell Signal; 2023 Jan; 101():110498. PubMed ID: 36273753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KNTC1 knockdown inhibits the proliferation and migration of osteosarcoma cells by MCM2.
    Zhong L; Dong Y; Liu S
    Mol Carcinog; 2024 May; ():. PubMed ID: 38818892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [YAP regulates the proliferation and modifies the sensitivity to sorafenib in hepatocellular carcinoma cells].
    Guo LW; Shao GL; Luo J; Hao WY; Yao Z; Zheng JP
    Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):818-823. PubMed ID: 30481931
    [No Abstract]   [Full Text] [Related]  

  • 5. Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.
    Huang XQ; Zhang XF; Xia JH; Chao J; Pan QZ; Zhao JJ; Zhou ZQ; Chen CL; Tang Y; Weng DS; Zhang JH; Xia JC
    Chin J Cancer; 2017 Sep; 36(1):77. PubMed ID: 28950898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. shRNA‑mediated knockdown of KNTC1 inhibits non-small-cell lung cancer through regulating PSMB8.
    Liu R; Liu R; Guo Z; Ren J; Huang J; Luo Q; Tan Q
    Cell Death Dis; 2022 Aug; 13(8):685. PubMed ID: 35933405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetochore-associated protein 1 promotes the invasion and tumorigenicity of cervical cancer cells via matrix metalloproteinase-2 and matrix metalloproteinase-9.
    Wang C; Wang Y; Liu C; Meng X; Hang Z
    Bioengineered; 2022 Apr; 13(4):9495-9507. PubMed ID: 35389773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. shRNA‑mediated knockdown of KNTC1 suppresses cell viability and induces apoptosis in esophageal squamous cell carcinoma.
    Liu CT; Min L; Wang YJ; Li P; Wu YD; Zhang ST
    Int J Oncol; 2019 Mar; 54(3):1053-1060. PubMed ID: 30628654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of KNTC1 Inhibits the Proliferation, Migration and Tumorigenesis of Human Bladder Cancer Cells and Induces Apoptosis.
    Huang H; Fan X; Qiao Y; Yang M; Ji Z
    Crit Rev Eukaryot Gene Expr; 2021; 31(1):49-60. PubMed ID: 33639055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of KNTC1 in the regulation of proliferation, migration and tumorigenesis in colorectal cancer.
    Wang J; Ding Z; Shu W; Zhuge Y
    Cell Signal; 2023 Aug; 108():110728. PubMed ID: 37230198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K/AKT pathway.
    Zheng Y; Wang X; Wang H; Yan W; Zhang Q; Chang X
    Tumour Biol; 2014 Jun; 35(6):5189-98. PubMed ID: 24573607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KNTC1 knockdown suppresses cell proliferation of colon cancer.
    Zhengxiang Z; Yunxiang T; Zhiping L; Zhimin Y
    3 Biotech; 2021 Jun; 11(6):262. PubMed ID: 33996374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KNTC1, regulated by HPV E7, inhibits cervical carcinogenesis partially through Smad2.
    Pan W; Wang S; Liu X; Wang M; Han X; Tian X; Lin J; Qiao X; Wang X
    Exp Cell Res; 2023 Feb; 423(1):113458. PubMed ID: 36608837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9.
    Gao J; Ding F; Liu Q; Yao Y
    Mol Cell Biochem; 2013 Apr; 376(1-2):21-32. PubMed ID: 23232575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
    Wang Z; Wei W; Sun CK; Chua MS; So S
    Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Yes1 Associated Transcriptional Regulator Inhibits Hepatocellular Carcinoma Progression and Improves Sensitivity to Sorafenib: An in vitro and in vivo Study.
    Guo L; Zheng J; Luo J; Zhang Z; Shao G
    Onco Targets Ther; 2020; 13():11071-11087. PubMed ID: 33149619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cells.
    Tsai SC; Yang JS; Peng SF; Lu CC; Chiang JH; Chung JG; Lin MW; Lin JK; Amagaya S; Wai-Shan Chung C; Tung TT; Huang WW; Tseng MT
    Int J Oncol; 2012 Oct; 41(4):1431-42. PubMed ID: 22858649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KNTC1 as a putative tumor oncogene in pancreatic cancer.
    Liu L; Chen H; Chen X; Yao C; Shen W; Jia C
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3023-3031. PubMed ID: 35852618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.